Metastatic hidradenocarcinoma: a report of two rare cases

Eur J Dermatol. 2023 Jun 1;33(3):241-244. doi: 10.1684/ejd.2023.4478.

Abstract

Background: Hidradenocarcinoma is a rare malignant sweat gland tumour, characterized by a slow but aggressive course, with high rates of local recurrence and metastasis. Due to its rarity, histological criteria and therapeutic guidelines are poorly defined, posing a major challenge for clinicians and pathologists.

Objectives: To present two new cases of metastatic hidradenocarcinoma as well as a review of the literature.

Materials & methods: We describe two case studies and a review of the literature based on a search using the MEDLINE (PubMed) electronic database.

Results: The first patient was a 61-year-old woman with a perimamillary hidradenocarcinoma that arose from the malignant transformation of a benign childhood lesion and developed regional lymph node metastases after wide excision and adjuvant radiotherapy. The second patient was a 63-year-old man who developed cutaneous and renal metastases several years after the complete excision of a lumbar hidradenocarcinoma. As far as we can ascertain, kidney metastasis from hidradenocarcinoma has not previously been described.

Conclusion: Most authors recommend wide excision as the treatment of choice for hidradenocarcinoma, however, optimal adjuvant therapy remains to be determined. Our cases add to the limited knowledge available, but high-quality studies to find new effective treatments are needed.

Keywords: Cutaneous adnexal neoplasms; eccrine carcinoma; hidradenocarcinoma; hidradenoma; sweat gland neoplasms.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Carcinoma, Skin Appendage*
  • Child
  • Combined Modality Therapy
  • Databases, Factual
  • Female
  • Humans
  • Kidney Neoplasms*
  • Male
  • Middle Aged
  • Skin Neoplasms*
  • Sweat Gland Neoplasms* / surgery